Affiliation:
1. Department of Cardiology Aarhus University Hospital Aarhus Denmark
2. Department of Clinical Medicine, Faculty of Health Aarhus University Aarhus Denmark
3. Department of Biomedicine, Faculty of Health Aarhus University Aarhus Denmark
4. Medical/Steno Aarhus Research Laboratory Aarhus University Aarhus Denmark
Abstract
Background
Pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) are debilitating diseases with a high mortality. Despite emerging treatments, pulmonary vascular resistance frequently remains elevated. However, the ketone body 3‐hydroxybutyrate (3‐OHB) may reduce pulmonary vascular resistance in these patients. Hence, the aim was to assess the hemodynamic effects of 3‐OHB in patients with PAH or CTEPH.
Methods and Results
We enrolled patients with PAH (n=10) or CTEPH (n=10) and residual pulmonary hypertension. They received 3‐OHB infusion and placebo (saline) for 2 hours in a randomized crossover study. Invasive hemodynamic and echocardiography measurements were performed. Furthermore, we investigated the effects of 3‐OHB on the right ventricle of isolated hearts and isolated pulmonary arteries from Sprague–Dawley rats. Ketone body infusion increased circulating 3‐OHB levels from 0.5±0.5 to 3.4±0.7 mmol/L (
P
<0.001). Cardiac output improved by 1.2±0.1 L/min (27±3%,
P
<0.001), and right ventricular annular systolic velocity increased by 1.4±0.4 cm/s (13±4%,
P
=0.002). Pulmonary vascular resistance decreased by 1.3±0.3 Wood units (18%±4%,
P
<0.001) with no significant difference in response between patients with PAH and CTEPH. In the rat studies, 3‐OHB administration was associated with decreased pulmonary arterial tension compared with saline administration (maximal relative tension difference: 12±2%,
P
<0.001) and had no effect on right ventricular systolic pressures (
P
=0.63), whereas pressures rose at a slower pace (dP/dtmax,
P
=0.02).
Conclusions
In patients with PAH or CTEPH, ketone body infusion improves cardiac output and decreases pulmonary vascular resistance. Experimental rat studies support that ketone bodies relax pulmonary arteries. Long‐term studies are warranted to assess the clinical role of hyperketonemia.
Registration
URL:
https://www.clinicaltrials.gov
; Unique identifier: NCT04615754.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献